NRx Pharmaceuticals Net Worth
NRx Pharmaceuticals Net Worth Breakdown | NRXPW |
NRx Pharmaceuticals Net Worth Analysis
NRx Pharmaceuticals' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including NRx Pharmaceuticals' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of NRx Pharmaceuticals' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform NRx Pharmaceuticals' net worth analysis. One common approach is to calculate NRx Pharmaceuticals' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares NRx Pharmaceuticals' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing NRx Pharmaceuticals' net worth. This approach calculates the present value of NRx Pharmaceuticals' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of NRx Pharmaceuticals' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate NRx Pharmaceuticals' net worth. This involves comparing NRx Pharmaceuticals' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into NRx Pharmaceuticals' net worth relative to its peers.
Enterprise Value |
|
To determine if NRx Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding NRx Pharmaceuticals' net worth research are outlined below:
| NRx Pharmaceuticals is way too risky over 90 days horizon | |
| NRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| NRx Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| NRx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (30.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NRx Pharmaceuticals has accumulated about 24.55 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| NRx Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: NRX Pharmaceuticals Strengthens Leadership with New CFO Appointment - TipRanks |
Follow NRx Pharmaceuticals' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 714.61 M.Market Cap |
|
Project NRx Pharmaceuticals' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.12) | (3.92) | |
| Return On Capital Employed | 2.35 | 2.47 | |
| Return On Assets | (4.12) | (3.92) | |
| Return On Equity | 2.57 | 2.70 |
When accessing NRx Pharmaceuticals' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures NRx Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of NRx Pharmaceuticals' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in NRx Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NRx Pharmaceuticals. Check NRx Pharmaceuticals' Beneish M Score to see the likelihood of NRx Pharmaceuticals' management manipulating its earnings.
Evaluate NRx Pharmaceuticals' management efficiency
NRx Pharmaceuticals has return on total asset (ROA) of (1.1597) % which means that it has lost $1.1597 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.8261) %, meaning that it generated substantial loss on money invested by shareholders. NRx Pharmaceuticals' management efficiency ratios could be used to measure how well NRx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, NRx Pharmaceuticals' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 2.70 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (3.92). At this time, NRx Pharmaceuticals' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 409.4 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (1.55) | (1.47) | |
| Tangible Book Value Per Share | (1.55) | (1.47) | |
| Enterprise Value Over EBITDA | (1.31) | (1.25) | |
| Price Book Value Ratio | (2.97) | (2.82) | |
| Enterprise Value Multiple | (1.31) | (1.25) | |
| Price Fair Value | (2.97) | (2.82) | |
| Enterprise Value | 39.4 M | 37.4 M |
Effective leadership at NRx Pharmaceuticals drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Return On Equity (6.83) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NRx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on NRx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NRx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Javitt Daniel C. over six months ago Disposition of 33018 shares by Javitt Daniel C. of NRx Pharmaceuticals at 1.0523 subject to Rule 16b-3 | ||
Kim Bennett over six months ago Insider Trading |
NRx Pharmaceuticals Earnings per Share Projection vs Actual
NRx Pharmaceuticals Corporate Management
| Suzanne Messere | Investor Relations | Profile | |
| Robert MIM | Chief Operations | Profile | |
| Michael Kunz | Gen Sec | Profile | |
| Molly Cogan | Sr Affairs | Profile | |
| Seth Voorhees | CFO Treasurer | Profile |
Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.